Stephens Investment Management Group LLC Sells 179 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Stephens Investment Management Group LLC decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.1% in the fourth quarter, HoldingsChannel reports. The firm owned 179,537 shares of the company’s stock after selling 179 shares during the quarter. Stephens Investment Management Group LLC’s holdings in Henry Schein were worth $12,424,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of HSIC. FMR LLC increased its stake in shares of Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP increased its position in Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares during the period. Nuance Investments LLC raised its holdings in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC lifted its position in shares of Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Henry Schein by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock valued at $85,662,000 after purchasing an additional 6,184 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $79.00 on Monday. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The firm’s 50-day moving average is $73.70 and its 200 day moving average is $71.80. The stock has a market cap of $9.85 billion, a price-to-earnings ratio of 32.51, a PEG ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Analyst Ratings Changes

A number of equities analysts recently issued reports on HSIC shares. Barrington Research increased their price target on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $80.10.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.